Biotech4Change conference - Victor Dillard and Thomas de Vlaam

Biotech4Change conference, on the 28th of September 2018.
This event was co-organized by iGEM UCLouvain and Young Change Maker. This is an interview of Victor Dillard and Thomas de Vlaam

Thomas de Vlaam had the ambition of becoming a neurosurgeon. He holds a bachelor’s degree in International Medicine and Global. Unfortunately after a diagnosis of Scheuermann’s disease, Thomas underwent significant spinal fusion surgery in 2011, forcing him to give up on his medical career.
Despite the physical challenges and long recovery periods, his dream of helping patients grew stronger and became an unstoppable driver. He joined ProQR – a biotech company in the Netherlands working on novel drugs to treat rare orphan disorders. He then invented and developed a completely new approach to treat Amyloid disorders.
At the age of 24, Thomas started his new company: Amylon.

Victor Dillard is a young Belgian based in London. He’s now a mondial reference for the biotech entrepreneurship! At the age of 24 he raised 3 million USD to create Desktop Genetics, a start-up that changed the way we conceive genetic engineering! Today, Victor is the CEO of this leading company in genome modification technologies, more particularly he associates AI (artificial intelligence) with CRISPR-Cas9 technology!
Victor was nominated Forbes 30 Under 30, MIT Innovator Under 35 and Entrepreneur of the Year by the MIT Technology Review!


-------
FACEBOOK : www.facebook.com/YoungChangeMaker
SITE : www.youngchangemaker.eu
--------